Literature DB >> 17913342

Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.

Tullio Florio1.   

Abstract

Activation of phosphotyrosine phosphatases (PTPs) by somatostatin receptor (SSTR) represents one of the main intracellular mechanisms involved in the antiproliferative effect of somatostatin (SST) and analogues. Since their molecular cloning, the role of PTPs is emerging as a major regulator of different cell functions including cell proliferation, differentiation, cell to cell interactions, cell matrix adhesion and cell migration. It was demonstrated that PTPs possess high substrate specificity and their activity is tightly regulated. Importantly, different G protein-coupled receptors transduce their biological activities through PTPs. PTPs were identified as down-stream effectors of SSTRs to transduce antiproliferative signals, and so far, three family members (SHP-1, SHP-2 and DEP-1/PTPeta) have been identified as selective SSTR intracellular effectors. Here, the molecular mechanisms leading SSTRs to regulate PTP activity are discussed, focusing on recent data showing a close interplay between PTPs and tyrosine kinases to transduce tumoral cell growth arrest following SST analogs administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913342     DOI: 10.1016/j.mce.2007.08.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  29 in total

1.  Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population.

Authors:  Jia-hong Chen; Hui-chan He; Fu-neng Jiang; Julia Militar; Petor-yang Ran; Guo-qiang Qin; Chao Cai; Xi-Bin Chen; Jin Zhao; Zi-yao Mo; Yan-ru Chen; Jian-guo Zhu; Xingyin Liu; Wei-de Zhong
Journal:  Med Oncol       Date:  2011-10-30       Impact factor: 3.064

2.  Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics.

Authors:  J Clay Callison; Ronald C Walker; Pierre P Massion
Journal:  J Lung Cancer       Date:  2011

3.  Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes.

Authors:  Sirilaksana Kunjara; A Leslie Greenbaum; Milena Sochor; Allan Flyvbjerg; Henning Grønbaek; Patricia McLean
Journal:  Int J Exp Pathol       Date:  2014-03-06       Impact factor: 1.925

4.  A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathway.

Authors:  Souad Najib; Nathalie Saint-Laurent; Jean-Pierre Estève; Stefan Schulz; Elisa Boutet-Robinet; Daniel Fourmy; Jens Lättig; Catherine Mollereau; Stéphane Pyronnet; Christiane Susini; Corinne Bousquet
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

5.  Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors.

Authors:  Jonathan Strosberg; Larry Kvols
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

Review 6.  Pituitary somatostatin receptor signaling.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Trends Endocrinol Metab       Date:  2010-02-09       Impact factor: 12.015

7.  Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.

Authors:  Fabrizio Griffero; Antonio Daga; Daniela Marubbi; Maria Cristina Capra; Alice Melotti; Alessandra Pattarozzi; Monica Gatti; Adriana Bajetto; Carola Porcile; Federica Barbieri; Roberto E Favoni; Michele Lo Casto; Gianluigi Zona; Renato Spaziante; Tullio Florio; Giorgio Corte
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

8.  Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation.

Authors:  Qisheng Liu; Mark S Bee; Agnes Schonbrunn
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

Review 9.  Medical treatment for gastro-entero-pancreatic neuroendocrine tumours.

Authors:  Rossana Berardi; Francesca Morgese; Mariangela Torniai; Agnese Savini; Stefano Partelli; Silvia Rinaldi; Miriam Caramanti; Consuelo Ferrini; Massimo Falconi; Stefano Cascinu
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

Review 10.  Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.

Authors:  Erika Peverelli; Donatella Treppiedi; Federica Mangili; Rosa Catalano; Anna Spada; Giovanna Mantovani
Journal:  Nat Rev Endocrinol       Date:  2021-06-30       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.